Provided by Tiger Trade Technology Pte. Ltd.

Emergent BioSolutions

8.05
-0.1400-1.71%
Post-market: 8.00-0.0500-0.62%16:51 EDT
Volume:844.49K
Turnover:6.82M
Market Cap:416.76M
PE:8.66
High:8.38
Open:8.21
Low:7.93
Close:8.19
52wk High:14.06
52wk Low:4.02
Shares:51.77M
Float Shares:51.26M
Volume Ratio:0.92
T/O Rate:1.65%
Dividend:- -
Dividend Rate:- -
EPS(TTM):0.9300
EPS(LYR):0.9300
ROE:10.46%
ROA:5.34%
PB:0.80
PE(LYR):8.66

Loading ...

Emergent BioSolutions Inc. Announces Annual Meeting of Stockholders

Reuters
·
Mar 21

Mpox Is on the Rise in the U.S. 3 Vaccine Stocks Worth a Second Look. -- Barrons.com

Dow Jones
·
Mar 18

Emergent Biosolutions Is Maintained at Buy by HC Wainwright & Co.

Dow Jones
·
Mar 09

U.S. RESEARCH ROUNDUP-Dow, Oracle, Shopify

Reuters
·
Mar 09

Emergent BioSolutions Inc. Files Initial Beneficial Ownership Statement for Director John D. Fowler Jr

Reuters
·
Mar 06

Press Release: Emergent BioSolutions Announces Appointment of John D. Fowler, Jr. to Board of Directors

Dow Jones
·
Mar 03

Nyse Order Imbalance 75175.0 Shares on Buy Side

THOMSON REUTERS
·
Mar 03

Emergent BioSolutions Down Over 25%, on Pace for Largest Percent Decrease Since August 2024 -- Data Talk

Dow Jones
·
Feb 28

Emergent Biosolutions Slide After Widening 4Q Loss, Logging Lower Revenue

Dow Jones
·
Feb 27

Emergent BioSolutions Shares Down 20% Premarket After Q4 Revenue Falls

THOMSON REUTERS
·
Feb 27

Emergent BioSolutions Inc reports results for the quarter ended September 30 - Earnings Summary

Reuters
·
Feb 27

Emergent BioSolutions sees FY26 revenue $720M-$760M, consensus $809.4M

TIPRANKS
·
Feb 27

Emergent BioSolutions sees Q1 revenue $135M-$155M, consensus $275M

TIPRANKS
·
Feb 27

Emergent BioSolutions reports Q4 EPS (43c) vs. 5c last year

TIPRANKS
·
Feb 27

Emergent BioSolutions authorizes $50M stock repurchase program

TIPRANKS
·
Feb 27

Emergent BioSolutions Reports Profitability Amid Ongoing Turnaround

TIPRANKS
·
Feb 27

BRIEF-Emergent BioSolutions Q4 Revenue USD 148.7 Million

Reuters
·
Feb 27

Emergent BioSolutions Outlook FY Adjusted Net Income USD 25-45 Million

THOMSON REUTERS
·
Feb 27

Emergent BioSolutions Q4 Gross Margin 30%

THOMSON REUTERS
·
Feb 27

Emergent BioSolutions Outlook FY Net Income USD -30 to -10 Million

THOMSON REUTERS
·
Feb 27